Autori: Perzeri Andreas L
| Naslov | High Dose Imatinib Induction Therapy (800 mg/day, 6 Months) In Pre-Treated Chronic Phase CML Patients Improves Cytogenetic and Molecular Responses but Does Not Improve Overall and Progression Free Survival - Final Results of the CELSG Phase III CML11 "ISTAHIT" Trial (Meeting Abstract) |
| Autori | Perzeri Andreas L ... Bogdanovic Andrija D ... (broj koautora 20) |
| Info | BLOOD, (2010), vol. 116 br. 21, str. 934-935 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
